- Home
- BDSX vs SABA Comparison
BDSX vs SABA Comparison
Compare BDSX & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDSX
- SABA
- Stock Information
- Founded
- BDSX 2005
- SABA 1988
- Country
- BDSX United States
- SABA United States
- Employees
- BDSX N/A
- SABA N/A
- Industry
- BDSX Precision Instruments
- SABA
- Sector
- BDSX Health Care
- SABA
- Exchange
- BDSX Nasdaq
- SABA Nasdaq
- Market Cap
- BDSX 194.9M
- SABA 246.4M
- IPO Year
- BDSX 2020
- SABA N/A
- Fundamental
- Price
- BDSX $1.51
- SABA $8.87
- Analyst Decision
- BDSX Strong Buy
- SABA
- Analyst Count
- BDSX 4
- SABA 0
- Target Price
- BDSX $3.08
- SABA N/A
- AVG Volume (30 Days)
- BDSX 332.5K
- SABA 290.0K
- Earning Date
- BDSX 11-01-2024
- SABA 01-01-0001
- Dividend Yield
- BDSX N/A
- SABA 12.91%
- EPS Growth
- BDSX N/A
- SABA N/A
- EPS
- BDSX N/A
- SABA N/A
- Revenue
- BDSX $65,562,000.00
- SABA N/A
- Revenue This Year
- BDSX $46.97
- SABA N/A
- Revenue Next Year
- BDSX $30.43
- SABA N/A
- P/E Ratio
- BDSX N/A
- SABA N/A
- Revenue Growth
- BDSX 48.92
- SABA N/A
- 52 Week Low
- BDSX $1.11
- SABA $3.64
- 52 Week High
- BDSX $2.21
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- BDSX 48.94
- SABA 49.76
- Support Level
- BDSX $1.24
- SABA $8.73
- Resistance Level
- BDSX $1.43
- SABA $9.14
- Average True Range (ATR)
- BDSX 0.10
- SABA 0.15
- MACD
- BDSX 0.01
- SABA -0.03
- Stochastic Oscillator
- BDSX 64.44
- SABA 32.27
About BDSX Biodesix Inc.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Templeton Global Income Fund is a closed-end fund. It seeks high current income, with a secondary goal of capital appreciation. Under normal market conditions. The Fund invests at least over 80% of its net assets in income-producing securities, including debt securities of the United States and foreign issuers, including emerging markets.